Meghna Rajesh, senior research analyst at Beroe, discusses how RTCT (real-time clinical trials) will impact supply chains and how sponsors need to consider that now.
Related Reading
08 May, 2026
GLP-1 Patent Expiry & the Rise of Generics: Transforming the Drug Delivery Device Landscape & Procurement Strategy
27 Aug, 2026
Pharmacovigilance outsourcing and global talent arbitrage: A procurement guide to cost, capability, and country choice